rs727504778
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PP3_ModerateBP6BS1
The NM_002230.4(JUP):c.1933G>A(p.Ala645Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000026 in 1,614,180 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A645V) has been classified as Uncertain significance.
Frequency
Consequence
NM_002230.4 missense
Scores
Clinical Significance
Conservation
Publications
- arrhythmogenic right ventricular dysplasia 12Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- inherited epidermolysis bullosaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- Naxos diseaseInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- lethal acantholytic epidermolysis bullosaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| JUP | NM_002230.4 | c.1933G>A | p.Ala645Thr | missense_variant | Exon 12 of 14 | ENST00000393931.8 | NP_002221.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| JUP | ENST00000393931.8 | c.1933G>A | p.Ala645Thr | missense_variant | Exon 12 of 14 | 1 | NM_002230.4 | ENSP00000377508.3 | ||
| JUP | ENST00000310706.9 | c.1933G>A | p.Ala645Thr | missense_variant | Exon 12 of 15 | 1 | ENSP00000311113.5 | |||
| JUP | ENST00000393930.5 | c.1933G>A | p.Ala645Thr | missense_variant | Exon 12 of 15 | 5 | ENSP00000377507.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152180Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251460 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461882Hom.: 1 Cov.: 38 AF XY: 0.0000358 AC XY: 26AN XY: 727244 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74464 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Naxos disease;C1969081:Arrhythmogenic right ventricular dysplasia 12 Uncertain:2
- -
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 645 of the JUP protein (p.Ala645Thr). This variant is present in population databases (rs727504778, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with JUP-related conditions. ClinVar contains an entry for this variant (Variation ID: 179306). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
The Ala645Thr variant in JUP has not been previously reported in the individuals with cardiomyopathy and was absent from large population studies. Computationa l analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen 2, and SIFT) do not provide strong support for or against an impact to the prote in. Additional information is needed to fully assess the clinical significance o f this variant. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at